Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens

Journal of Comparative Neurology

Volumn 495, Issue 3, 2006, Pages 299-313

  Pickel, Virgina M ^a   Chan, Jane ^a   Kearn, Christopher S ^b   Mackie, Kenneth ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Basal ganglia; Drug addiction; Marijuana; Motor inhibition; Reward

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS; DOPAMINE; DOPAMINE 2 RECEPTOR; ENDOCANNABINOID;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BIOAVAILABILITY; BRAIN REGION; CELL MEMBRANE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITE; DRUG DEPENDENCE; ELECTRON MICROSCOPY; EUPHORIA; IMMUNOCYTOCHEMISTRY; MALE; MOTOR ACTIVITY; NERVE ENDING; NERVE FIBER; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD; SYNAPSE; ULTRASTRUCTURE;

ANIMALS; DENDRITES; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEUS ACCUMBENS; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D2;

EID: 33144488036     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20881     Document Type: Article

References (76)

1. Angulo JA, McEwen BS. 1994. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Brain Res Rev 19:1-28.
2. Benoit-Marand M, Borrelli E, Gonon F. 2001. Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 21:9134-9141.
3. Bouaboula M, Bianchini L, McKenzie FR, Pouyssegur J, Casellas P. 1999. Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways. FEBS Lett 449:61-65.
4. Brana C, Aubert I, Charron G, Pellevoisin C, Bloch B. 1997. Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study. Mol Brain Res 48:389-400.
5. Calabresi P, Pisani A, Centonze D, Bernardi G. 1997a. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci Biobehav Rev 21:519-523.
6. Calabresi P, Pisani A, Centonze D, Bernardi G. 1997b. Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission. Nihon Shinkei Seishin Yakurigaku Zasshi 17:101-104.
7. Centonze D, Battista N, Rossi S, Mercuri NB, Finazzi-Agro A, Bernardi G, Calabresi P, Maccarrone M. 2004. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology 29:1488-1497.
8. Chan J, Aoki C, Pickel VM. 1990. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127.
9. Colombo MI, Mayorga LS, Nishimoto I, Ross EM, Stahl PD. 1994. Gs regulation of endosome fusion suggests a role for signal transduction pathways in endocytosis. J Biol Chem 269:14919-14923.
10. Curran EJ, Watson SJ Jr. 1995. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J Comp Neurol 361:57-76.
11. Dalia A, Uretsky NJ, Wallace LJ. 1998. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain Res 788:111-117.
12. Dani JA, Zhou FM. 2004. Selective dopamine filter of glutamate striatal afferents. Neuron 4:522-24.
13. de Bruin NM, Ellenbroek BA, Van Luijtelaar EL, Cools AR, Stevens KE. 2001. Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell. Neuroscience 105:169-180.
14. 2 receptor within GABAergic neurons of the rat striatum. Brain Res 746:239-255.
15. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D. 2004. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl 1):227-241.
16. Duarte C, Alonso R, Bichet N, Cohen C, Soubrie P, Thiebot MH. 2004. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior. Neuropsychopharmacology 29:911-920.
17. Eilam D, Szechtman H. 1989. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151-157.
18. Fritzsche M. 2001. Are cannabinoid receptor knockout mice animal models for schizophrenia? Med Hypotheses 56:638-643.
19. Gardner EL, Vorel SR. 1998. Cannabinoid transmission and reward-related events. Neurobiol Dis 5:502-533.
20. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. 2001. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-154.
21. Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D. 2004. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29:2108-2114.
22. Glass M, Felder CC. 1997. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17:5327-5333.
23. Glass M, Dragunow M, Faull RL. 1997. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299-318.
24. Gruenberg J, Griffiths G, Howell KE. 1989. Characterization of the early endosome and putative endocytic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J Cell Biol 108:1301-1316.
25. Harkany T, Hartig W, Berghuis P, Dobszay MB, Zilberter Y, Edwards RH, Mackie K, Ernfors P. 2003. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons. Eur J Neurosci 18:1979-1992.
26. Heimer L, Alheid GF, De Olmos JS, Groenewegen HJ, Haber SN, Harlan RE, Zahm DS. 1997. The accumbens: beyond the core-shell dichotomy. J Neuropsychiatry Clin Neurosci 9:354-381.
27. Herkenham M, Lynn AB, Johnson MR, Melvin LS, De Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
28. Hermann H, Marsicano G, Lutz B. 2002. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109:451-460.
29. 1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37:71-80.
30. Hurd YL, Herkenham M. 1995. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience 64:571-586.
31. Jaber M, Robinson SW, Missale C, Caron MG. 1996. Dopamine receptors and brain function. Neuropharmacology 35:1503-1519.
32. Jarrahian A, Watts VJ, Barker EL. 2004. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 308:880-886.
33. Jongen-Relo AL, Kaufmann S, Feldon J. 2002. A differential involvement of the shell and core subterritories of the nucleus accumbens of rats in attentional processes. Neuroscience 111:95-109.
34. Kalivas PW, Duffy P. 1997. Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761:173-177.
35. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:4544-4558.
36. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. 2001. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518.
37. Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. 2005. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67:1697-1704.
38. Koch M, Schmid A, Schnitzler HU. 2000. Role of nucleus accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology (Berl) 152:67-73.
39. Kofalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlagh B. 2005. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J Neurosci 25:2874-2884.
40. Le Foll B, Goldberg SR. 2004. Cannabinoid CB1 antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 321:875-883.
41. Leranth C, Pickel VM. 1989. Electron microscopic pre-embedding double immunostaining methods. In: Heimer L, Zaborszky L, editors. Neuroanatomical tract-tracing methods 2: recent progress. New York: Plenum, p 129-172.
42. Mailleux P, Vanderhaeghen JJ. 1992. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
43. Martin RS, Secchi RL, Sung E, Lemaire M, Bonhaus DW, Hedley LR, Lowe DA. 2003. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat. Psychopharmacology (Berl) 165:128-135.
44. Meredith GE, De Souza IEJ, Hyde TM, Tipper G, Wong ML, Egan MF. 2000. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J Neurosci 20:7798-7806.
45. Morari M, Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L. 1998. Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int 33:383-397.
46. Mukhopadhyay S, Shim JY, Assi AA, Norford D, Howlett AC. 2002. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chem Phys Lipids 121:91-109.
47. Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco, I, Villanua MA, Maldonado R, Koob GF, De Fonseca FR. 2001. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344-5350.
48. Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1997. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907.
49. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
50. Peters A, Palay SL, Webster Hd. 1991. The fine structure of the nervous system. New York: Oxford University Press.
51. Pickel VM, Chan J, Kash TL, Rodriguez JJ, Mackie K. 2004. Compartment-specific localization of cannabinoid 1 (CB1) and μ-opioid receptors in rat nucleus accumbens. Neuroscience 127:101-112.
52. Prekeris R, Klumperman J, Chen YA, Scheller RH. 1998. Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes. J Cell Biol 143:957-971.
53. Prekeris R, Foletti DL, Scheller RH. 1999. Dynamics of tubulovesicular recycling endosomes in hippocampal neurons. J Neurosci 19:10324-10337.
54. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208.
55. Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ. 2001. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 21:109-116.
56. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ. 2002. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A 99:8384-8388.
57. Rodriguez JJ, Mackie K, Pickel VM. 2001. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21:823-833.
58. Rodriguez de Fonsesca, F, del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. 2005. The endocannabinoid system: physiology and pharmacology. Alcohol 40:2-14.
59. Romero J, De Miguel R, Garcia-Palomero E, Fernandez-Ruiz JJ, Ramos JA. 1995. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res 694:223-232.
60. Ronesi J, Lovinger DM. 2005. Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J Physiol 562:245-256.
61. Samson HH, Chappell A. 2003. Dopaminergic involvement in medial prefrontal cortex and core of the nucleus accumbens in the regulation of ethanol self-administration: a dual-site microinjection study in the rat. Physiol Behav 79:581-590.
62. Samson HH, Chappell AM. 2004. Effects of raclopride in the core of the nucleus accumbens on ethanol seeking and consumption: the use of extinction trials to measure seeking. Alcohol Clin Exp Res 28:544-549.
63. Seachrist JL, Ferguson SS. 2003. Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74:225-235.
64. Sesack SR, Pickel VM. 1990. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527:266-279.
65. Sesack SR, Pickel VM. 1992. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145-160.
66. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
67. Stanley-Gary CC, Harris C, Martin-Iverson MT. 2002. Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat. Behav Pharmacol 13:15-28.
68. Stefani A, Pisani A, Bernardi G, Bonci A, Mercuri NB, Stratta F, Calabresi P. 1995. The modulation of dopamine receptors in rat striatum. J Neural Transm Suppl 45:61-66.
69. 1 dopamine receptor messenger RNAs during cocaine abstinence. Mol Brain Res 56:162-168.
70. Szabo B, Siemes S, Wallmichrath I. 2002. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 15:2057-2061.
71. Umemiya M, Raymond LA. 1997. Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. J Neurophys 78:1248-1255.
72. van der Stelt M, Di Marzo V. 2003. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 480:133-150.
73. Wager-Miller J, Westenbroek R, Mackie K. 2002. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem Phys Lipids 121:83-89.
74. Wan FJ, Swerdlow NR. 1996. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res 722:168-176.
75. Wilson RI, Kunos G, Nicoll RA. 2001. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462.
76. Zahm DS. 2000. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24:85-105.